Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| GUN | Gunsynd | AIM | £1.39M | 0.09 | 9.50% | |
| VAL | ValiRx | AIM | £2.08M | 0.27 | -2.20% | |
| PRM | Proteome Sciences | AIM | £4.96M | 1.50 | 8.00% | |
| OPTI | OptiBiotix Health | AIM | £5.01M | 4.94 | -3.30% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| FUM | Futura Medical | AIM | £5.17M | 0.83 | 14.60% | |
| VRCI | Verici Dx | AIM | £7.19M | 0.46 | -4.80% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| OBD | Oxford BioDynamics | AIM | £9.23M | 0.19 | -4.00% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| GDR | Genedrive | AIM | £14.69M | 0.91 | -1.60% | |
| IXI | Ixico | AIM | £14.99M | 6.78 | -1.50% | |
| AREC | Arecor Therapeutics | AIM | £24.92M | 63.21 | -1.30% | |
| SBTX | SkinBioTherapeutics | AIM | £25.27M | 9.75 | -14.90% | |
| IMM | ImmuPharma | AIM | £25.58M | 4.05 | -3.00% | |
| EDEN | Eden Research | AIM | £26.51M | 3.23 | -2.40% | |
| SAR | Sareum Holdings | AIM | £28.99M | 20.90 | -5.60% | |
| POLB | Poolbeg Pharma | AIM | £31.38M | 4.36 | -2.10% | |
| ABDX | Abingdon Health | AIM | £36.84M | 8.01 | 2.60% | |
| HVO | Hvivo | AIM | 0.03 | £51.53M | 7.50 | -5.10% |
| OBI | Ondine Biomedical Inc | AIM | £61.05M | 11.75 | 2.60% | |
| EAH | Eco Animal Health Group | AIM | £63.02M | 93.00 | -4.30% | |
| ANIC | Agronomics | AIM | £70.26M | 6.78 | -0.60% | |
| FARN | Faron Pharmaceuticals OY | AIM | £77.21M | 41.99 | 1.10% | |
| 4BB | 4basebio | AIM | £78.16M | 525.45 | -0.40% | |
| BVXP | Bioventix | AIM | 8.96 | £87.52M | 1,703.50 | -2.20% |
| STX | Shield Therapeutics | AIM | £94.02M | 8.75 | -7.90% | |
| ANP | Anpario | AIM | 2.40 | £107.1M | 520.00 | -0.90% |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| SCLP | Scancell Holdings | AIM | £141.66M | 13.90 | -1.10% | |
| DXRX | Diaceutics | AIM | £146.03M | 166.00 | -0.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| ANCR | Animalcare Group | AIM | 2.12 | £169.16M | 245.00 | -2.60% |
| BTG | BTG | AIM | 3.68 | £192.69M | 119.50 | -0.10% |
| PRTC | Puretech Health | FTSE Small Cap | £310.6M | 138.80 | 8.78% | |
| AVCT | Avacta Group | AIM | £326.36M | 72.00 | -7.00% | |
| AGY | Allergy Therapeutics | AIM | £633.25M | 10.95 | -2.50% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £725.41M | 593.00 | -1.17% | |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| GNS | Genus | FTSE 250 | 1.41 | £1.56B | 2,356.00 | 0.51% |
| HCM | Hutchmed China | AIM | £1.71B | 195.00 | 4.80% | |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.50 | £3.03B | 1,408.00 | 0.68% |
| HLN | Haleon | FTSE 100 | 2.09 | £30.23B | 344.10 | 1.21% |
| GSK | GSK | FTSE 100 | 3.75 | £78.2B | 1,901.00 | -1.43% |
| AZN | AstraZeneca | FTSE 100 | 1.73 | £216.33B | 13,512.00 | -3.13% |